| abstract |
The present invention provides pharmaceutical uses for dihydropyrimidine compounds and their pharmaceutical uses, particularly for use in treating or preventing HBV disease. In particular, the present invention provides a compound having formula (I) or (Ia) as defined herein, or an enantiomer, diastereoisomer, tautomer, hydrate, solvate or pharmaceutically acceptable salt thereof do. The present invention also relates to the use of a compound having formula (I) or (Ia), or an enantiomer, diastereoisomer, tautomer, hydrate, solvate or pharmaceutically acceptable salt thereof for the treatment and prevention of HBV disease Lt; / RTI > |